AZELAPRAG AMGEN - AN OVERVIEW

AMG 986 exposures elevated nonlinearly with rising doses; negligible accumulation was noticed. In HF with lowered ejection fraction clients, there were numerical boosts in p.c changes from baseline in LV ejection fraction and stroke quantity by volumetric evaluation with AMG 986 vs placebo (stroke volume improve not recapitulated by Doppler).CONCLU